Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms

Detalles Bibliográficos
Autores principales: Hoertel, Nicolas, Sánchez-Rico, Marina, Cougoule, Céline, Gulbins, Erich, Kornhuber, Johannes, Carpinteiro, Alexander, Becker, Katrin Anne, Reiersen, Angela M., Lenze, Eric J., Seftel, David, Lemogne, Cédric, Limosin, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359627/
https://www.ncbi.nlm.nih.gov/pubmed/34385600
http://dx.doi.org/10.1038/s41380-021-01254-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359627/
https://www.ncbi.nlm.nih.gov/pubmed/34385600
http://dx.doi.org/10.1038/s41380-021-01254-3

Ejemplares similares